financetom
Business
financetom
/
Business
/
Scilex Issues Preliminary Q1 Sales Results for ZTlido
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scilex Issues Preliminary Q1 Sales Results for ZTlido
Apr 16, 2024 11:37 AM

02:09 PM EDT, 04/16/2024 (MT Newswires) -- Scilex Holding ( SCLX ) said Tuesday that Q1 net sales of ZTlido are expected to be between $12 million and $13 million, compared with $10.6 million in Q1 2023.

The company also said that it plans to reduce research and development costs and other administrative expenses and focus on its late-stage pipeline programs like SP-102.

Scilex ( SCLX ) shares fell 10% in recent trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Entegris' Fiscal Q1 Adjusted Earnings Rise While Net Sales Drop; Fiscal Q2 Outlook Set
Entegris' Fiscal Q1 Adjusted Earnings Rise While Net Sales Drop; Fiscal Q2 Outlook Set
May 1, 2024
06:48 AM EDT, 05/01/2024 (MT Newswires) -- Entegris ( ENTG ) reported fiscal Q1 non-GAAP earnings Wednesday of $0.68 per diluted share, up from $0.65 a year earlier. Analysts polled by Capital IQ expected $0.62. Net sales for the quarter ended March 30 was $771 million, down from $922.4 million a year earlier. Analysts surveyed by Capital IQ expected $771.6...
GSK Q1 Core Earnings, Revenue Advance; 2024 Outlook Lifted -- Shares Up Pre-Bell
GSK Q1 Core Earnings, Revenue Advance; 2024 Outlook Lifted -- Shares Up Pre-Bell
May 1, 2024
06:54 AM EDT, 05/01/2024 (MT Newswires) -- GSK (GSK) reported Q1 core earnings Wednesday of 0.431 British pounds ($0.54) per share, up from 0.37 pounds a year earlier. Analysts polled by Capital IQ expected 0.37 pounds. Turnover for the quarter ended March 31 was 7.36 billion pounds, up from 6.95 billion pounds a year earlier. Analysts surveyed by Capital IQ...
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
May 1, 2024
(Reuters) -Pfizer ( PFE ) lifted its annual profit forecast on Wednesday, banking on cost cuts and better-than-expected demand for its COVID antiviral treatment and vaccine. The U.S. drugmaker's shares rose nearly 3% before the bell after the company said it expects adjusted earnings per share of $2.15 to $2.35 in 2024 compared with a prior forecast of $2.05 to...
Generac Holdings' Q1 Adjusted Earnings, Revenue Rise
Generac Holdings' Q1 Adjusted Earnings, Revenue Rise
May 1, 2024
06:47 AM EDT, 05/01/2024 (MT Newswires) -- Generac Holdings ( GNRC ) reported Q1 adjusted earnings Wednesday of $0.88 per diluted share, up from $0.63 a year earlier. Analysts polled by Capital IQ expected $0.71. Revenue for the quarter ended March 31 was $889.3 million, compared with $887.9 million a year ago. Analysts surveyed by Capital IQ expected $892.7 million....
Copyright 2023-2026 - www.financetom.com All Rights Reserved